| Leveraging decagonal in-silico strategies for uncovering IL-6 inhibitors with precision AK Swaroop, PKK Namboori, M Esakkimuthukumar, TK Praveen, ... Computers in Biology and Medicine 163, 107231, 2023 | 8 | 2023 |
| Targeting of ErbB1, ErbB2, and their dual targeting using small molecules and natural peptides: Blocking EGFR cell signaling pathways in cancer: A mini-review SK Patnaik, MJN Chandrasekar, P Nagarjuna, D Ramamurthi, ... Mini Reviews in Medicinal Chemistry 22 (22), 2831-2846, 2022 | 7 | 2022 |
| In-silico docking and molecular dynamic introspective study of multiple targets of AChE with Rivastigmine and NMDA receptors with Riluzole for Alzheimer’s disease N Chintha, S Jupudi, N Palathoti, J Bharathi J, A Justin Journal of Biomolecular Structure and Dynamics 41 (22), 12620-12631, 2023 | 3 | 2023 |
| Virtual high throughput screening of natural peptides against ErbB1 and ErbB2 to identify potential inhibitors for cancer chemotherapy SK Patnaik, S Ayyamperumal, D Jade, N Palathoti, KS Akey, S Jupudi, ... Journal of Biomolecular Structure and Dynamics, 1-24, 2023 | 3 | 2023 |
| Discovery of immunomodulators from plant kingdom targeting IL-6 for the effective management therapy of SARS-CoV-2 AK Swaroop, P Nagarjuna, P Naresh, PS Sundar, S Jubie, J Natarajan, ... Journal of Natural Remedies, 249-260, 2022 | 3 | 2022 |
| Synthesis and Characterization of Dipeptide–Drug Conjugate: The Use of Linker Coupling Reaction D Ramamurthi, J Selvaraj, SK Patnaik, N Palathoti, R Rajeshkumar, ... International Journal of Peptide Research and Therapeutics 28 (2), 53, 2022 | 3 | 2022 |
| Peptides for Dual Targeting of ErbB1 and ErbB2: Blocking EGFR Cell Signaling Transduction Pathways for Cancer Chemotherapy. SK Patnaik, AK Swaroop, P Nagarjuna, MJ Nanjan, MJN Chandrasekar Current Molecular Pharmacology, 2023 | 2 | 2023 |
| Computational design for the development of natural molecules as compelling inhibitors against the target SARS-CoV-2: An in-silico attempt N Palathoti, K Rajagopal, G Byran, K Raman, E Jose, M Gurunathan Journal of Applied Pharmaceutical Science 13 (1), 034-040, 2023 | 1 | 2023 |
| Neurotrophin mimetics and tropomyosin kinase receptors: a futuristic pharmacological tool for Parkinson’s N Palathoti, M Dhanasekaran, R Sivasamy, S Ponnusankar, SP Dhanabal, ... Neurological Sciences 44 (7), 2265-2275, 2023 | 1 | 2023 |
| Ceftriaxone induces glial EAAT‐2 promotor region via NF‐kB conformational changes: An interaction analysis using HADDOCK GN Rao, S Jupudi, P Pant, N Palathoti, K Rajagopal, R Govindasamy, ... Journal of Cellular Biochemistry 124 (3), 359-372, 2023 | 1 | 2023 |
| GlmU inhibitors as promising antibacterial agents: a review N Palathoti, MA Azam Mini Reviews in Medicinal Chemistry 23 (3), 343-360, 2023 | 1 | 2023 |
| Methicillin-Resistant Staphylococcus aureus Infection and its Health Perspective: A Review. A Thomas, N Palathoti, MA Azam Current Pharmaceutical Biotechnology, 2024 | | 2024 |
| Design, Synthesis and In vitro Screening of Novel 2-Mercaptobenzothiazole-Clubbed Phenylacetamides as Potential Antibacterial Agents SR Gurram, MA Azam, N Palathoti Letters in Drug Design & Discovery 21 (7), 1185-1194, 2024 | | 2024 |
| Preliminary screening of Pioglitazone and Diosgenin novel combination for Alzheimer’s disease S Mohammed, A Nandhyala, NR Gaddam, K Rajagopal, N Palathoti, ... Journal of Applied Pharmaceutical Science 13 (1), 065-075, 2023 | | 2023 |
| Exploring the NMDAR antagonists as potential therapeutic agents in the treatment of Alzheimer’s disease-A Review N Dugar, J Mathew, N Palathoti, G Swaminathan, S Jupudi, MA Azam | | 2023 |
